• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    More On BTGGF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    BTG plc (BTGGF)

    -Other OTC
    8.50 Up 0.17(2.04%) May 5, 9:31AM EDT
    Prev Close:8.33
    Open:8.48
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:0.592127
    Next Earnings Date:N/A
    Day's Range:8.48 - 8.50
    52wk Range:8.00 - 12.24
    Volume:5,700
    Avg Vol (3m):1,053
    Market Cap:3.25B
    P/E (ttm):49.13
    EPS (ttm):0.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for BTGGF at this time.

    Key Statistics

    Forward P/E (1 yr):0.35
    P/S (ttm):5.39
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-16) :19.30
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):0.94

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BTG plc, a specialist healthcare company, acquires, develops, and commercializes pharmaceutical products worldwide. It operates through three segments: Interventional Medicine, Specialty Pharmaceuticals, and Licensing. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback